1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Radiopharmaceutical Theranostics Market – by Product Type

1.3.2        Middle East & Africa Radiopharmaceutical Theranostics Market – by Radioisotope

1.3.3        Middle East & Africa Radiopharmaceutical Theranostics Market – by Source

1.3.4        Middle East & Africa Radiopharmaceutical Theranostics Market – by Application

1.3.5        Middle East & Africa Radiopharmaceutical Theranostics Market – by Indication

1.3.6        Middle East & Africa Radiopharmaceutical Theranostics Market – by End User

1.3.7        Middle East & Africa Radiopharmaceutical Theranostics Market – by Country

2.           Middle East & Africa Radiopharmaceutical Theranostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East & Africa Radiopharmaceutical Theranostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East & Africa PEST Analysis

4.3         Expert’s Opinion

5.           Middle East & Africa Radiopharmaceutical Theranostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Incidence of Cancer

5.1.2        Rising Application in Treatment of Cardiovascular Disorders

5.2         Market Restraints

5.2.1        Regulatory Challenges for Approval of Radiopharmaceutical Theranostics

5.3         Market Opportunities

5.3.1        Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies

5.4         Future Trends

5.4.1        Radiopharmaceutical Theranostics in Nuclear Medicine

5.5         Impact Analysis

6.           Radiopharmaceutical Theranostics Market – Middle East & Africa Analysis

6.1         Middle East & Africa Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis

7.           Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – by Product Type

7.1         Overview

7.2         Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)

7.2.1        Positron Emission Tomography (PET) Tracers

7.2.1.1          Overview

7.2.1.2          Positron Emission Tomography (PET) Tracers: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

7.2.2        Beta Emitters

7.2.2.1          Overview

7.2.2.2          Beta Emitters: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

7.2.3        Alpha Emitters

7.2.3.1          Overview

7.2.3.2          Alpha Emitters: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Middle East & Africa Radiopharmaceutical Theranostics Market Analysis – by Radioisotope

8.1         Overview

8.2         Radiopharmaceutical Theranostics Market Revenue Share, by Radioisotope 2021 & 2028 (%)

8.2.1        Technetium-99

8.2.1.1          Overview

8.2.1.2          Technetium-99: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.2        Gallium-68

8.2.2.1          Overview

8.2.2.2          Gallium-68: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.3        Iodine-131

8.2.3.1          Overview

8.2.3.2          Iodine-131: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4        Iodine-123

8.2.4.1          Overview

8.2.4.2          Iodine-123: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.5        Fluorine-18 (18F)

8.2.5.1          Overview

8.2.5.2          Fluorine-18 (18F): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.6        Yttrium 90 (Y-90)

8.2.6.1          Overview

8.2.6.2          Yttrium 90 (Y-90): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.7        Lutetium (LU) 177

8.2.7.1          Overview

8.2.7.2          Lutetium (LU) 177: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.8        Copper (CU) 67

8.2.8.1          Overview

8.2.8.2          Copper (CU) 67: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.9        Copper (CU) 64

8.2.9.1          Overview

8.2.9.2          Copper (CU) 64: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.10     Others

8.2.10.1       Overview

8.2.10.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Middle East & Africa Radiopharmaceutical Theranostics Market Analysis – by Source

9.1         Overview

9.2         Radiopharmaceutical Theranostics Market Revenue Share, by Source 2021 & 2028 (%)

9.2.1        Nuclear Reactors

9.2.1.1          Overview

9.2.1.2          Nuclear Reactors: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.2        Cyclotrons

9.2.2.1          Overview

9.2.2.2          Cyclotrons: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Middle East & Africa Radiopharmaceutical Theranostics Market Analysis – by Application

10.1      Overview

10.2      Radiopharmaceutical Theranostics Market Revenue Share, by Application 2021 & 2028 (%)

10.2.1     Targeted Therapeutic (Rx)

10.2.1.1       Overview

10.2.1.2       Targeted Therapeutics (Rx): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.2     Companion Diagnostic (CDx)

10.2.2.1       Overview

10.2.2.2       Companion Diagnostics (CDx): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.        Middle East & Africa Radiopharmaceutical Theranostics Market Analysis – by Indication

11.1      Overview

11.2      Radiopharmaceutical Theranostics Market Revenue Share, by Indication 2021 & 2028 (%)

11.2.1     Oncology

11.2.1.1       Overview

11.2.1.2       Oncology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.2     Neurology

11.2.2.1       Overview

11.2.2.2       Neurology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.3     Cardiology

11.2.3.1       Overview

11.2.3.2       Cardiology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.4     Others

11.2.4.1       Overview

11.2.4.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.        Middle East & Africa Radiopharmaceutical Theranostics Market Analysis – by End User

12.1      Overview

12.2      Radiopharmaceutical Theranostics Market Revenue Share, by End User 2021 & 2028 (%)

12.2.1     Hospitals

12.2.1.1       Overview

12.2.1.2       Hospitals: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.2     Diagnostic Imaging Centers

12.2.2.1       Overview

12.2.2.2       Diagnostic Imaging Centers: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.3     Academic & Research Institutes

12.2.3.1       Overview

12.2.3.2       Academic & Research Institutes: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.4     Others

12.2.4.1       Overview

12.2.4.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.        Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – by Country Analysis

13.1      Middle East & Africa Radiopharmaceutical Theranostics Market

13.1.1     Overview

13.1.2     Middle East & Africa: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)

13.1.2.1       Saudi Arabia: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.1       Overview

13.1.2.1.2       Saudi Arabia Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.3       Saudi Arabia Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.1.4       Saudi Arabia Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.1.5       Saudi Arabia Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.1.6       Saudi Arabia Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.1.7       Saudi Arabia Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.1.8       Saudi Arabia Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.2       South Africa: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.1       Overview

13.1.2.2.2       South Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.3       South Africa Radiopharmaceutical Theranostics Market, by Product type, 2019–2028 (US$ Million)

13.1.2.2.4       South Africa Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.2.5       South Africa Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.2.6       South Africa Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.2.7       South Africa Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.2.8       South Africa Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.3       UAE: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.1       Overview

13.1.2.3.2       UAE Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.3       UAE Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.3.4       UAE Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.3.5       UAE Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.3.6       UAE Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.3.7       UAE Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.3.8       UAE Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.4       Rest of Middle East & Africa: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.1       Overview

13.1.2.4.2       Rest of Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.3       Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.4.4       Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.4.5       Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.4.6       Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.4.7       Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.4.8       Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

14.        Radiopharmaceutical Theranostics Market – Industry Landscape

14.1      Overview

14.2      Growth Strategies in the Radiopharmaceutical Theranostics Market

14.3      Inorganic Growth Strategies

14.3.1     Overview

14.4      Organic Growth Strategies

14.4.1     Overview

15.        Company Profiles

15.1      Bayer AG

15.1.1     Key Facts

15.1.2     Business Description

15.1.3     Products and Services

15.1.4     Financial Overview

15.1.5     SWOT Analysis

15.1.6     Key Developments

15.2      Curium

15.2.1     Key Facts

15.2.2     Business Description

15.2.3     Products and Services

15.2.4     Financial Overview

15.2.5     SWOT Analysis

15.2.6     Key Developments

15.3      Telix Pharmaceuticals Ltd.

15.3.1     Key Facts

15.3.2     Business Description

15.3.3     Products and Services

15.3.4     Financial Overview

15.3.5     SWOT Analysis

15.3.6     Key Developments

15.4      Siemens Healthineers AG

15.4.1     Key Facts

15.4.2     Business Description

15.4.3     Products and Services

15.4.4     Financial Overview

15.4.5     SWOT Analysis

15.4.6     Key Developments

16.        Appendix

16.1      About The Insight Partners

16.2      Glossary of Terms

LIST OF TABLES

Table 1.             Saudi Arabia Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Saudi Arabia Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Saudi Arabia Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Saudi Arabia Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Saudi Arabia Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Saudi Arabia Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             South Africa Radiopharmaceutical Theranostics Market, by Product type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             South Africa Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 9.             South Africa Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 10.          South Africa Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11.          South Africa Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 12.          South Africa Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          UAE Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          UAE Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 15.          UAE Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 16.          UAE Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 17.          UAE Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 18.          UAE Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Recent Inorganic Growth Strategies in the Radiopharmaceutical Theranostics Market

Table 26.          Recent Organic Growth Strategies in the Radiopharmaceutical Theranostics Market

Table 27.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Middle East & Africa Radiopharmaceutical Theranostics Market Segmentation

Figure 2.           Middle East & Africa Radiopharmaceutical Theranostics Market, by Country

Figure 3.           Middle East & Africa Radiopharmaceutical Theranostics Market Overview

Figure 4.           Positron Emission Tomography (PET) Tracers Segment Held Largest Share of Product Type Segment in Radiopharmaceutical Theranostics Market

Figure 5.           Saudi Arabia Expected to Show Remarkable Growth During Forecast Period

Figure 6.           Middle East & Africa: PEST Analysis

Figure 7.           Middle East & Africa Experts’ Opinion

Figure 8.           Middle East & Africa Radiopharmaceutical Theranostics Market: Impact Analysis of Drivers and Restraints

Figure 9.           Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue Forecast and Analysis – 2020–2028

Figure 10.        Middle East & Africa Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)

Figure 11.        Positron Emission Tomography (PET) Tracers: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Beta Emitters: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Alpha Emitters: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Middle East & Africa Radiopharmaceutical Theranostics Market, by Radioisotope, 2021 & 2028 (%)

Figure 15.        Technetium-99: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Gallium-68: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Iodine-131: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Iodine-123: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Fluorine-18 (18F): Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Yttrium 90 (Y-90): Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Lutetium (LU) 177: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Copper (CU) 67: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Copper (CU) 64: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Others: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Middle East & Africa Radiopharmaceutical Theranostics Market, by Source, 2021 & 2028 (%)

Figure 26.        Nuclear Reactors: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Cyclotrons: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Middle East & Africa Radiopharmaceutical Theranostics Market, by Application, 2021 & 2028 (%)

Figure 29.        Targeted Therapeutics (Rx): Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Companion Diagnostics (CDx): Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Middle East & Africa Radiopharmaceutical Theranostics Market, by Indication, 2021 & 2028 (%)

Figure 32.        Oncology: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Neurology: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Cardiology: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Others: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Middle East & Africa Radiopharmaceutical Theranostics Market, by End User, 2021 & 2028 (%)

Figure 37.        Hospitals: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Diagnostic Imaging Centers: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Academic & Research Institutes: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Others: Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        Middle East & Africa: Radiopharmaceutical Theranostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 42.        Saudi Arabia Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43.        South Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44.        UAE Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45.        Rest of Middle East & Africa Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46.        Growth Strategies in the Radiopharmaceutical Theranostics Market